Potential health benefits and safety considerations regarding human consumption of tea seed oil and olive oil

Faculty of Medicine, Thammasat University0 个研究点目标入组 12 人开始时间: 2015年3月14日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•a)Healthy nonsmoking, non-alcohol consuming male aged 18-45 years old.
•b)Body mass index (BMI) within 18-25 kg/m2.
•c)Four weeks before screening for study entry, volunteers will withdraw from any drugs that may affect the blood lipid level.
•d)Volunteers who are in good health on basis of medical history and physical examination.
•e)Volunteers who understand the study method, and sign the consent form, willing to comply with the study protocol.
•f)Volunteers with normal lipid profiles and hematological, liver or kidney functions as evaluated by routine blood tests, including complete blood count (CBC), blood urea nitrogen (BUN), creatinine (Cr), fasting blood sugar (FBS) and liver function test (LFT).

•a)Volunteers with a history of bleeding disorders or glucose-6-phosphate dehydrogenase deficiency or thalassemia.
•b)Volunteers with dyslipidemia (total cholesterol (TC) â‰¥ 240 mg/dL; low-density lipoprotein cholesterol (LDL-C) â‰¥ 160 mg/dL; triacylglycerol (TAG) â‰¥ 200 mg/dL).
•c)Volunteers who take drugs affecting the blood lipid level four weeks before enrollment in the study.
•d)Volunteers who have other medical conditions, which in the opinion of the investigators, put the volunteers at risk participating the study.

发起方

Faculty of Medicine, Thammasat University